BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18198628)

  • 1. [Antiphospholipid syndrome: from diagnosis to treatment].
    Martinović D; Radić M; Fabijanić D; Fabijanić A
    Lijec Vjesn; 2007; 129(8-9):281-5. PubMed ID: 18198628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid syndrome: an evolving story.
    Robertson B; Greaves M
    Blood Rev; 2006 Jul; 20(4):201-12. PubMed ID: 16442679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention.
    Tufano A; Guida A; Di Minno MN; De Gregorio AM; Cerbone AM; Di Minno G
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):217-23. PubMed ID: 20153613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of antiphospholipid syndrome.
    Tuthill JI; Khamashta MA
    J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome.
    Erkan D; Lockshin MD
    Curr Opin Rheumatol; 2006 May; 18(3):242-8. PubMed ID: 16582686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome.
    Christodoulou C; Sangle S; D'Cruz DP
    Rheumatology (Oxford); 2007 Jun; 46(6):907-10. PubMed ID: 17403711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatment of antiphospholipid syndrome: lights and shadows.
    Espinosa G; Cervera R
    Nat Rev Rheumatol; 2015 Oct; 11(10):586-96. PubMed ID: 26122952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study.
    Martinez-Zamora MA; Peralta S; Creus M; Tassies D; Reverter JC; Espinosa G; Cervera R; Carmona F; Balasch J
    Ann Rheum Dis; 2012 Jan; 71(1):61-6. PubMed ID: 21900285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome.
    Crowther MA
    Thromb Res; 2004; 114(5-6):443-6. PubMed ID: 15507276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and antiphospholipid syndrome: the treatment debate.
    Ruiz-Irastorza G; Khamashta MA
    Rheumatology (Oxford); 2005 Aug; 44(8):971-4. PubMed ID: 15840602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies.
    Mecacci F; Bianchi B; Pieralli A; Mangani B; Moretti A; Cioni R; Giorgi L; Mello G; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Mar; 48(3):246-9. PubMed ID: 19109318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiphospholipid syndrome in the year 2009].
    Buliková A; Zavrelová J; Penka M
    Vnitr Lek; 2009 Mar; 55(3):253-62. PubMed ID: 19378856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.